Evidence map›Paper›PMID 36051081›Full record

ArticleEJHaem2022

A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus.

Christopher Dittus, Natalie Grover, Tarsheen Sethi, Jonathon B Cohen, Alfredo Voloschin, Janhvi Rabadey, Xianming Tan, Anne Beaven, Steven I Park

Abstract read
In one paragraph

Article in EJHaem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Real-world challenges in primary central nervous system lymphoma: a case series.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christopher DittusDivision of Hematology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.ORCID https://orcid.org/0000-0002-9794-7908
Natalie GroverDivision of Hematology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
Tarsheen SethiDivision of Hematology Yale University New Haven Connecticut USA.
Jonathon B CohenDepartment of Hematology and Medical Oncology Emory University-Winship Cancer Institute Atlanta Georgia USA.
Alfredo VoloschinDepartment of Hematology and Medical Oncology Emory University-Winship Cancer Institute Atlanta Georgia USA.
Janhvi RabadeyDivision of Hematology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
Xianming TanDepartment of Biostatistics University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
Anne BeavenDivision of Hematology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
Steven I ParkAtrium Health Levine Cancer Institute Charlotte North Carolina USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

central nervous system lymphomachemotherapyHIVnon‐Hodgkin lymphomaoutcomes

Identifiers

PMID36051081
PMCPMC9421958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.